Blood Group Typing Market is Expanding at a CAGR of 9.3% by 2027

Increase in Number of Accidental and Trauma Cases Who Need Blood Transfusion Expected to Accelerate the Market Across the Globe. The Global Blood Group Typing Market was valued USD 1.9 Bn in 2020 is expected to reach US$ 3.6 Bn by 2027, with a growing CAGR of 9.3% during the forecast period (2021-2027).

For the blood transfusion, the blood group typing is necessary to avoid life risking immune response. As the cases of trauma and accident rises, the rate of blood transfusion also increases which is considerably the major driving factor for the growth of the global blood group typing market. Moreover, the awareness about blood donation is increasing among the population due to multiple organizations to promote blood donation camps is another driving factor for the growth of the blood group typing market.

The report provides an in-depth analysis of market trends, financial analysis, segmentation analysis, company profiles, recent news and much more. Blood group typing market is segmented into type, product, techniques, end user, and region.

Based on type, the antibody screening segment is anticipated to hold the largest market in the forecast period. Based on products, the target market is segmented into reagents, instruments, and kits. Further, Based on techniques, the blood group typing market is divided into massively parallel sequencing, assay-based techniques, PCR-based and microarray techniques, other techniques. Assay-based techniques is dominating the global blood group typing market as it is an economical and time saving method. Based on the end-user, the market is segmented into blood banks, clinical laboratories, hospitals, and others.

Geographically, the North American region is dominating the blood group typing market with the highest revenue. The supremacy is attributed to high healthcare expenditure, high healthcare related awareness, and incorporation of enhanced and sophisticated healthcare infrastructure in the region. Moreover, the another driving factor influencing the blood group typing market includes growing incidences of trauma, kidney related disorders, and cancer patients who need blood transfusion.

However, Asia pacific region is witnessing the highest CAGR in the near future owing to the continuous developments in healthcare infrastructure, economic development, and untapped opportunities in these developing nations. Additionally, the growing awareness about blood donation is anticipated to grow at the fastest rate during the forecast period.

Report also covers analysis of some of the key players including Sucuri Inc., Immucor Inc., Merck KGaA, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, BAG Health Care GmbH, Quotient, Novacyt Group, Beckman Coulter Inc. and among others. These players have significantly adopted varied developmental strategies covered in our reports. The report also covers numerous market trends and upcoming opportunities in the near future.

Global Blood Group Typing Market Report Highlights

Based on technique, the assay-based techniques segment accounted the highest share in 2020 as it is a time saving and cost effective technique.
By end-user, the clinical laboratories segment registered for the largest share in the market in 2020. The growth is attributed to government taking initiative to emerge laboratories.

Recent News

In January 2019, the FDA (Food and Drug Administration) approved to launch the Erytra Eflexis analyser of Grifols, which is fully automated. This analyzer analyses the blood for transfusion with the technology called DG Gel technology.
In October 2017, Ortho Clinical Diagnostics Inc., launched the reagent that used in the method to test extended phenotype. The reagent is approved by the US FDA (Food and Drug Administration).

The Global Blood Group Typing Market Segmentation:

The global blood group typing market is segmented into type, product, techniques, end-user, and region.

The Global Blood Group Typing Industry Segmentation:

By Type